TFPI and non-small cell lung carcinoma: Levels of five of the six candidate biomarkers tested (CEA, MDK, MMP2, SLPI, TIMP1, TFPI) were significantly higher in serum from subjects with NSCLC than in controls (Table 3, Additional file 7: Figure S4), serving to support this indirect discovery approach.